Cite
Immunogenicity and safety of a novel adjuvanted hepatitis B candidate vaccine in liver transplant patients
MLA
UCL - Autre, et al. “Immunogenicity and Safety of a Novel Adjuvanted Hepatitis B Candidate Vaccine in Liver Transplant Patients.” Journal of Hepatology, Vol. 40, p. 52 (2004), 2004. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1130549890&authtype=sso&custid=ns315887.
APA
UCL - Autre, Nevens, F., Zuckerman, J., Burroughs, A., Jung, M., Bayas, J., Kallinowski, B., de la Mata, M., Duvoux, C., Neuhaus, P., Saliba, F., Buti, M., Zarski, J., Pons, F., Vanlemmens, C., Hamtiaux, V., Stoffel, M., & 39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver. (2004). Immunogenicity and safety of a novel adjuvanted hepatitis B candidate vaccine in liver transplant patients. Journal of Hepatology, Vol. 40, p. 52 (2004).
Chicago
UCL - Autre, Frederik Nevens, Jn Zuckerman, A Burroughs, Mc Jung, Jm Bayas, B Kallinowski, et al. 2004. “Immunogenicity and Safety of a Novel Adjuvanted Hepatitis B Candidate Vaccine in Liver Transplant Patients.” Journal of Hepatology, Vol. 40, p. 52 (2004). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1130549890&authtype=sso&custid=ns315887.